TransMedics GroupTMDX +3.44%69 Days Inventory is 61.93 as of Mar. 2026, which is 84% below its 10-year median of 383.94. GuruFocus rates TMDX with a GF Score™ of 69/100 and a GF Value™ of $167.77 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 786 Medical Devices & Instruments companies, TransMedics Group ranks better than 91.98% on this metric.
The historical rank and industry rank for TransMedics Group's Days Inventory or its related term are showing as below:
TMDX'
s Days Inventory Range Over the Past 10 Years
Min: 63.28 Med: 383.94 Max: 537.16
Current: 63.28
During the past 10 years, TransMedics Group's highest Days Inventory was 537.16. The lowest was 63.28. And the median was 383.94.
TMDX's Days Inventory is ranked better than 91.98% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs TMDX: 63.28
TransMedics Group's Days Inventory
declined
from Mar. 2025 (74.19) to Mar. 2026 (61.93).
Inventory Turnover measures how fast the company turns over its inventory within a year.
TransMedics Group's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TransMedics Group's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.28.
TransMedics Group (NAS:TMDX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
TransMedics Group's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TransMedics Group's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
TransMedics Group Days Inventory Related Terms
TransMedics Group Days Inventory Historical Data
* Premium members only.
The historical data trend for TransMedics Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMDX vs AXGN, BFLY, ESTA: Days Inventory Comparison
For the Medical Devices subindustry, TransMedics Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where TransMedics Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (TMDX) has a Days Inventory of 61.93 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on TransMedics Group and its competitors. This is 84% below median its historical median of 383.94. Over the past decade, TransMedics Group's Days Inventory has ranged from 63.28 to 537.16. According to the industry distribution chart, TransMedics Group ranks #63 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 8%.
Is TransMedics Group's Days Inventory too high?
TransMedics Group's current Days Inventory of 61.93 is 84% below median its 10-year median of 383.94. Over the past 10 years, this metric has ranged from a low of 63.28 to a high of 537.16. The Medical Devices & Instruments industry median Days Inventory is 179.60. TransMedics Group's value of 61.93 is 65.5% below this industry median. Based on the distribution chart, TransMedics Group ranks #63 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TransMedics Group has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TransMedics Group's Days Inventory compare to AXGN and BFLY?
According to the Medical Devices & Instruments industry distribution chart, TransMedics Group ranks #63 out of 786 companies for Days Inventory. This places TransMedics Group in the top 8% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. TransMedics Group's value of 61.93 is 65.5% below this benchmark. Historically, TransMedics Group's own Days Inventory has ranged from 63.28 to 537.16 over the past decade. While the company's 10-year median is 383.94 vs. the industry median of 179.60, TransMedics Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TransMedics Group's current Days Inventory of 61.93 is 65.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on TransMedics Group and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransMedics Group's current Days Inventory is 61.93, which is 84% below median its own 10-year median of 383.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransMedics Group stock overvalued right now?
Based on GuruFocus' analysis, TransMedics Group (TMDX) is currently considered Possible Value Trap. The stock's GF Value™ is $167.77, compared to a current price of $71.23 — trading 57.5% below its estimated fair value. The current Days Inventory is 61.93, which is 84% below median its 10-year median of 383.94 and 65.5% below the Medical Devices & Instruments industry median of 179.60. TransMedics Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For TransMedics Group (TMDX), the current Days Inventory is 61.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TransMedics Group (TMDX) Overvalued in 2026?
Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued.
The current stock price of $71.23 is trading 57.5% below its estimated GF Value™ of $167.77.
GuruFocus considers TransMedics Group to be Possible Value Trap.
Key valuation signals for TMDX:
Days Inventory: 61.93 (84% below median its 10-year median of 383.94)
GF Value™: $167.77 vs. price of $71.23 (57.5% below fair value)
Industry Position: 65.5% below the Medical Devices & Instruments median (#63 of 786)
No single metric tells the full story. See the TMDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score
Get the complete analysis for TMDX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TMDX has been successfully added to your 
